Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open-label, and single-arm Phase 1 study

Clin Transl Med. 2023 Aug;13(8):e1387. doi: 10.1002/ctm2.1387.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2* / genetics
  • mRNA Vaccines

Supplementary concepts

  • SARS-CoV-2 variants